All stock lists
Grupo Cibest S.A. (New York Stock Exchange:CIB)
CO · Delayed Price · Currency is USD
Financial Services · Banks - Regional
92.37+0.15 (+0.16%)
Market cap
$21.8B
Insider Score
Health Score
Analyst consensus
Listed since
Jul 26, 1995
Website
Insider Score
––Not scored
CIB Insider Score
No insider has filed an open-market purchase or sale here in the last 90 days, so there is nothing to score yet.
CIB analyst forecast
CIB analyst consensus
Moderate Buy2 ratings
Buy 1 Hold 1 Sell 0
Based on each firm’s most recent rating in the last 3 months — one vote per firm, so a desk that reiterates weekly does not count three times.
CIB 12-month price target
No published price targets in the last 12 months.
CIB ratings mix, last 12 months
Buy Hold Sell
Best analysts covering CIB
- Goldman Sachs25%success rate · -41.5% avg return · 4 calls
- JP Morgan0%success rate · -46.4% avg return · 4 calls
Measured by us from each firm’s own rating dates and this stock’s split- and dividend-adjusted closes. How we calculate this.
CIB analyst ratings
| Firm | Price target | Action | ||||
|---|---|---|---|---|---|---|
| — | JP Morgan | Neutral | — | — | Downgraded | 2026-09-16 |
| — | Goldman Sachs | Buy | — | — | Reiterated | 2026-08-13 |
| — | JP Morgan | Overweight | — | — | Upgraded | 2026-08-11 |
| — | Goldman Sachs | Buy | — | — | Upgraded | 2026-07-28 |
| — | Goldman Sachs | Neutral | — | — | Reiterated | 2026-07-16 |
| — | B of A Securities | Neutral | — | — | Upgraded | 2026-06-01 |
| — | JP Morgan | Neutral | — | — | Reiterated | 2026-05-18 |
| — | UBS | Neutral | — | — | Reiterated | 2026-04-23 |
| — | Itau BBA | Underperform | — | — | Downgraded | 2026-02-26 |
| — | Goldman Sachs | Neutral | — | — | Reiterated | 2026-02-25 |
| — | Citigroup | Neutral | — | — | Downgraded | 2026-01-22 |
| — | Goldman Sachs | Neutral | — | — | Upgraded | 2026-01-13 |
| — | JP Morgan | Neutral | — | — | Reiterated | 2025-11-21 |
| — | B of A Securities | Underperform | — | — | Downgraded | 2025-09-11 |
| — | B of A Securities | Neutral | — | — | Upgraded | 2025-08-07 |
| — | UBS | Neutral | — | — | Reiterated | 2025-06-02 |
| — | Goldman Sachs | Sell | — | — | Reiterated | 2025-02-24 |
| — | Morgan Stanley | Overweight | — | — | Upgraded | 2025-01-28 |
| — | B of A Securities | Underperform | — | — | Downgraded | 2024-08-29 |
| — | Goldman Sachs | Sell | — | — | Downgraded | 2024-08-20 |
| — | JP Morgan | Underweight | — | — | Reiterated | 2024-08-12 |
| — | JP Morgan | Underweight | — | — | Reiterated | 2024-07-10 |
| — | JP Morgan | Underweight | — | — | Reiterated | 2024-04-16 |
| — | Goldman Sachs | Neutral | — | — | Downgraded | 2023-09-21 |
| — | Itau BBA | Market Perform | — | — | Downgraded | 2023-08-30 |
| — | Goldman Sachs | Buy | — | — | Reiterated | 2023-08-11 |
| — | JP Morgan | Underweight | — | — | Downgraded | 2023-08-10 |
| — | B of A Securities | Neutral | — | — | Downgraded | 2023-04-28 |
| — | UBS | Neutral | — | — | Upgraded | 2022-10-19 |
| — | Credit Suisse | Outperform | — | — | Upgraded | 2022-08-02 |
| — | JP Morgan | Neutral | — | — | Downgraded | 2022-04-12 |
| — | Goldman Sachs | Buy | — | — | Upgraded | 2022-03-03 |
| — | Credit Suisse | Neutral | — | — | Upgraded | 2021-08-04 |
| — | JP Morgan | Neutral | — | — | Downgraded | 2020-07-29 |
| — | Credit Suisse | Underperform | — | — | Downgraded | 2020-03-13 |
| — | HSBC | Buy | — | — | Upgraded | 2020-02-26 |
| — | JP Morgan | Overweight | — | — | Reiterated | 2020-02-24 |
| — | JP Morgan | Overweight | — | — | Upgraded | 2019-08-06 |
| — | Credit Suisse | Neutral | — | — | Upgraded | 2019-08-06 |
| — | Credit Suisse | Underperform | — | — | Downgraded | 2019-04-30 |
| — | Citigroup | Buy | — | — | Upgraded | 2019-04-17 |
| — | Santander | Underperform | — | — | Downgraded | 2018-11-19 |
| — | JP Morgan | Neutral | — | — | Reiterated | 2018-03-16 |
| — | Standpoint Research | Accumulate | — | — | Upgraded | 2018-03-07 |
| — | HSBC | Hold | — | — | Downgraded | 2017-08-15 |
| — | Standpoint Research | Hold | — | — | Downgraded | 2017-05-22 |
| — | Morgan Stanley | Overweight | — | — | Upgraded | 2016-12-13 |
| — | Credit Suisse | Neutral | — | — | Downgraded | 2016-10-06 |
| — | Deutsche Bank | Buy | — | — | Upgraded | 2016-08-22 |
| — | Goldman Sachs | Neutral | — | — | Downgraded | 2016-03-29 |
| — | Barclays | Underweight | — | — | Reiterated | 2016-03-24 |
| — | UBS | Sell | — | — | Downgraded | 2016-03-16 |
| — | Bank of America | Neutral | — | — | Downgraded | 2016-03-14 |
| — | B of A Securities | Neutral | — | — | Downgraded | 2016-03-14 |
| — | Credit Suisse | Outperform | — | — | Upgraded | 2016-03-07 |
| — | HSBC | Buy | — | — | Upgraded | 2015-12-16 |
| — | Barclays | Underweight | — | — | Downgraded | 2015-12-02 |
| — | JP Morgan | Neutral | — | — | Reiterated | 2015-10-28 |
| — | Standpoint Research | Buy | — | — | Upgraded | 2015-08-14 |
| — | JP Morgan | Overweight | — | — | Upgraded | 2015-07-23 |
CIB earnings vs. estimates
| Quarter | EPS est. | EPS actual | Revenue est. | Revenue actual |
|---|---|---|---|---|
| 2025-11-06 | 1.81 | 2.18 | $2.01B | $2.76B |
| 2026-02-23 | 2.04 | 1.77 | $1.97B | $1.69B |
| 2026-05-04 | 1.84 | 1.62 | $2.04B | $2.00B |
| 2026-08-10 | 2.14 | 3.32 | $2.28B | $2.43B |
| 2026-11-09Upcoming | 2.96 | — | $2.55B | — |
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.